Synapse

← Nikolaos Dagres

Papers by Nikolaos Dagres

Page 4 · newest first

  1. Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trialClinical Research in Cardiology · 2019
  2. Clinical impact of antithrombotic therapy in transvenous lead extraction complications: a sub-analysis from the ESC-EORP EHRA ELECTRa (European Lead Extraction ConTRolled) RegistryEP Europace · 2019
  3. Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS)EP Europace · 2019
  4. Remote monitoring, healthcare costs, and workload for healthcare professionalsEuropean Heart Journal · 2019
  5. Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association surveyEP Europace · 2019
  6. Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and meta-analysisIJC Heart & Vasculature · 2019
  7. Atrial fibrillation: A review of modifiable risk factors and preventive strategiesRomanian Journal of Internal Medicine · 2019
  8. Atrial fibrillation history impact on catheter ablation outcome. Findings from the ESC‐EHRA Atrial Fibrillation Ablation Long‐Term RegistryPacing and Clinical Electrophysiology · 2019
  9. Prevention of sudden cardiac death by the implantable cardioverter-defibrillatorPolskie Archiwum Medycyny Wewnętrznej · 2018
  10. Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-AnalysisEP Europace · 2018
  11. Catheter ablation of atrial fibrillation: current status, techniques, outcomes and challengesCatheter ablation of atrial fibrillation: current status, techniques, outcomes, and challengesKardiologia Polska · 2018
  12. Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillationPLoS ONE · 2018
  13. Impact of body mass index on the outcome of catheter ablation of atrial fibrillationHeart · 2018
  14. Rate of acquired pulmonary vein stenosis after ablation of atrial fibrillation referred to electroanatomical mapping systems: Does it matter?Cardiology Journal · 2018
  15. Cryoballoon vs. radiofrequency ablation for atrial fibrillation: a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish catheter ablation registryEP Europace · 2018
  16. Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial FibrillationJournal of the American Heart Association · 2018
  17. Factors determining the choice between subcutaneous or transvenous implantable cardioverter-defibrillators in Poland in comparison with other European countries: a sub-study of the European Heart Rhythm Association prospective surveyKardiologia Polska · 2018
  18. Arrhythmias and cognitive functionEuropean Heart Journal · 2018
  19. Cardiac resynchronization therapy in heart failure: is the defibrillator needed?EP Europace · 2018
  20. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS)EP Europace · 2018
  21. Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association SurveyEP Europace · 2018
  22. Prediction of electro-anatomical substrate using APPLE score and biomarkersEP Europace · 2018
  23. Management of patients with ventricular arrhythmias and prevention of sudden cardiac death—translating guidelines into practice: results of the European Heart Rhythm Association surveyEP Europace · 2018
  24. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI)EP Europace · 2018
  25. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?SHILAP Revista de lepidopterología · 2018
  26. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECEEP Europace · 2018
  27. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?EP Europace · 2018
  28. Initial apixaban dosing in patients with atrial fibrillationClinical Cardiology · 2018
  29. Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessmentEP Europace · 2018
  30. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective surveyEP Europace · 2018
  31. Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association surveyEP Europace · 2018
  32. European Sudden Cardiac Arrest network: towards Prevention, Education and New Effective Treatments (ESCAPE-NET)European Heart Journal · 2018
  33. Sleep Disorders and Atrial Fibrillation: Current Situation and Future Directions.2018
  34. Patients’ knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm AssociationEP Europace · 2017
  35. Determinants of occurrence and survival after sudden cardiac arrest–A European perspective: The ESCAPE-NET projectResuscitation · 2017
  36. Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association SurveyEP Europace · 2017
  37. Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation: a randomized studyEP Europace · 2017
  38. Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS)EP Europace · 2017
  39. Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association surveyEP Europace · 2017
  40. Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial FibrillationAdvances in Therapy · 2017
  41. Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association SurveyEP Europace · 2017
  42. Approach to cardio-oncologic patients with special focus on patients with cardiac implantable electronic devices planned for radiotherapy: results of the European Heart Rhythm Association surveyEP Europace · 2017
  43. Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)EP Europace · 2017
  44. Innovation in cardiovascular disease in Europe with focus on arrhythmias: current status, opportunities, roadblocks, and the role of multiple stakeholdersEP Europace · 2017
  45. Supraventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy associate with long-term outcome after catheter ablation of ventricular tachycardiasEP Europace · 2017
  46. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease—indications in the post-DANISH trial era: results of the European Heart Rhythm Association surveyEP Europace · 2017
  47. Epicardial ablation may not be necessary in all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and frequent ventricular tachycardiaEP Europace · 2017
  48. Cryoablation for treatment of cardiac arrhythmias: results of the European Heart Rhythm Association surveyEP Europace · 2017
  49. Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk FactorAdvances in Therapy · 2016
  50. Catheter ablation for atrial flutter: a survey by the European Heart Rhythm Association and Canadian Heart Rhythm SocietyEP Europace · 2016